In Italy, the occupation of beds in intensive care by Covid patients returns to exceed the critical threshold of 30 percent. This is what emerges from the monitoring carried out by Agenas (National Agency for Regional Health Services) updated on 9 March
Intensive care beyond the critical threshold
Nationwide, ICUs occupied by Sars-Cov-2 positive people now reach 31 percent. In this way, the level beyond which it is difficult to adequately assist other non-Covid patients is exceeded. Compared to the data of March 25, growth was strong: from 31 to 6 per cent, in practice XNUMX points more than the percentage.
Meanwhile, according to the data released by the Ministry of Health, today they are registered 22.409 new positive cases (yesterday 19.749). The new deaths are 332 (yesterday 376). The discharged healed today are 13.752 (yesterday 12.999); altogether the new positive cases are 487.074 (yesterday 478.883). The swabs carried out are 361.040, the ICU patients are 2.827 while they remain in home isolation 461.365 people infected with Covid.
The Sputnik V will also be produced in Italy
The first agreement in Europe has been signed between the Russian government fund and the company Adienne Pharma & Biotech for the production in Italy of the Sputnik V vaccine. Italian-Russian Chamber of Commerce in a note published on its website. The partnership will allow production to start as early as July 2021.
“The innovative production process of the Russian vaccine Sputnik it will help to create new jobs and will allow Italy to control the entire production process of the preparation. This will allow the production of 10 million doses by the end of the year ”. This was reiterated by the Italian-Russian Chamber of Commerce which announces the signing of the first agreement in Europe between the Russian government fund and the company Adienne Pharma & Biotech for the production of Russian whey in Italy.
Vaccines, obtain multiple doses from a vial
When administering anti Covid vaccines, it is necessary to "try to obtain as many doses as possible from each vial of vaccine, without prejudice to the guarantee of injecting each subject with the correct dose and the availability of adequate syringes". The Technical Scientific Commission (Cts) of theItalian Medicines Agency (Aifa). Last January the AIFA had addressed the question of the doses obtainable from vaccine bottles Pfizer, authorizing the withdrawal of a sixth dose.
In fact, it was established that "with the aim of using all the product available in each vial and avoiding any waste, AIFA, in accordance with the provisions of its Technical Scientific Commission, it is possible to have at least 1 additional dose compared to the 5 doses declared in Summary of Product Characteristics (Rcp). This, ensuring the administration of the correct amount of 0.3 ml to each subject, vaccinated through the use of syringes adequate ".